Clinical trials
Obesity trials in Czechia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
96 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 3 |
| 2007 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 3 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 6 |
| 2018 | 4 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 8 |
| 2023 | 10 |
| 2024 | 7 |
| 2025 | 21 |
| 2026 | 15 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 36 |
| Recruiting | 23 |
| Active, not recruiting | 17 |
| Unknown status | 9 |
| Terminated | 7 |
| Not yet recruiting | 2 |
| Enrolling by invitation | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 16 |
| Novo Nordisk A/S | 9 |
| Amgen | 7 |
| Charles University, Czech Republic | 7 |
| University Hospital Ostrava | 5 |
| Gelesis, Inc. | 4 |
| Pfizer | 4 |
| Sanofi | 4 |
| Boehringer Ingelheim | 3 |
| University of Ostrava | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Obesity | 96 |
| Overweight | 41 |
| Diabetes Mellitus, Type 2 | 22 |
| Diabetes Mellitus | 10 |
| Hypertension | 4 |
| Insulin Resistance | 4 |
| Liver Cirrhosis | 4 |
| Obesity, Morbid | 4 |
| Sleep Apnea, Obstructive | 4 |
| Fatty Liver | 3 |
Trials
Showing 76 to 96 of 96. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.